D. Jacobsohn

发表

An update on the clinical utility of extracorporeal photopheresis in the treatment of graft-versus-host disease

Baheyeldin Salem, J. Webb, D. Jacobsohn, 2017 .

Optimal management of chronic graft‐versus‐host disease in children

D. Jacobsohn, 2010, British journal of haematology.

Chronic Graft-Versus-Host Disease in Children

K. Schultz, D. Jacobsohn, G. Vogelsang, 2006 .

Emerging therapies for graft-versus-host disease

D. Jacobsohn, 2003, Expert opinion on emerging drugs.

Veno-occlusive disease after high-dose busulfan–melphalan in neuroblastoma

A. Seif, S. Grupp, G. Yanik, 2018, Bone Marrow Transplantation.

Follow‐Up of Children after Hematopoietic Stem Cell Transplantation: growth and Development

K. Hardy, D. Jacobsohn, E. Perez-Albuerne, 2013 .

Advancement of pediatric blood and marrow transplantation research in North America: priorities of the Pediatric Blood and Marrow Transplant Consortium.

Allen R. Chen, M. Cairo, E. Horwitz, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Late Cardiovascular Morbidity and Mortality Following Pediatric Allogeneic Hematopoietic Cell Transplantation

B. Shaw, M. Flowers, Paul L Martin, 2018, Bone Marrow Transplantation.

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

M. Turner, J. Wingard, Stephanie J. Lee, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study.

J. Kurtzberg, G. Broadwater, V. Prasad, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Favorable outcome for infant acute lymphoblastic leukemia after hematopoietic stem cell transplantation.

W. Tse, D. Jacobsohn, M. Kletzel, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Intravenous anakinra for tisagenlecleucel-related toxicities in children and young adults

Elizabeth M. Wells, A. Angiolillo, D. Jacobsohn, 2021, Pediatric hematology and oncology.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease

H. Greinix, Stephanie J. Lee, M. Flowers, 2015 .

Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium.

B. Kurland, J. Pidala, Stephanie J. Lee, 2012, Blood.

Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.

B. Storer, J. Pidala, Stephanie J. Lee, 2011, Blood.

Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease.

J. Klein, M. Horowitz, J. Wingard, 2011, Blood.

EOSINOPHILIA CORRELATES WITH THE PRESENCE OR DEVELOPMENT OF CHRONIC GRAFT-VERSUS-HOST DISEASE IN CHILDREN

R. Seshadri, D. Jacobsohn, K. Thormann, 2004, Transplantation.

Infliximab for steroid‐refractory acute GVHD: A case series

L. Morris, D. Jacobsohn, G. Vogelsang, 2003, American journal of hematology.

Outcomes After Second Hematopoietic Cell Transplant for Children and Young Adults with Relapsed Acute Leukemia

Chi-kong Li, K. Myers, P. Mehta, 2019 .

Long-term survival and late effects among one-year survivors of second allogeneic hematopoietic cell transplantation for relapsed acute leukemia and myelodysplastic syndromes.

M. Norkin, W. Wood, M. Sorror, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical guide to fertility preservation in hematopoietic cell transplant recipients

M. Sorror, J. Wingard, J. Pidala, 2014, Bone Marrow Transplantation.

Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR).

M. Sorror, J. Wingard, M. Gilleece, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation

M. Norkin, S. Choi, M. Qayed, 2021, Blood advances.

Acute graft-versus-host disease in children

D. Jacobsohn, 2008, Bone Marrow Transplantation.

Late effects in hematopoietic cell transplant recipients with acquired severe aplastic anemia: a report from the late effects working committee of the center for international blood and marrow transplant research.

W. Wood, M. Sorror, M. Aljurf, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Early elevation of C-reactive protein correlates with severe infection and nonrelapse mortality in children undergoing allogeneic stem cell transplantation.

A. Rademaker, Jennifer L. McNeer, D. Jacobsohn, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Weight loss and malnutrition in patients with chronic graft-versus-host disease

D. Jacobsohn, G. Vogelsang, V. Anders, 2002, Bone Marrow Transplantation.

Novel Pharmacotherapeutic Approaches to Prevention and Treatment of GVHD

D. Jacobsohn, G. Vogelsang, 2012, Drugs.

Novel therapeutics for the treatment of graft-versus-host disease

D. Jacobsohn, 2002, Expert opinion on investigational drugs.

FAM treatment for new onset bronchiolitis obliterans syndrome after hematopoietic cell transplantation

J. Pidala, Stephanie J. Lee, M. Flowers, 2016 .

Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.

B. Storer, J. Pidala, Stephanie J. Lee, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pulmonary symptoms measured by the NIH Lung score predict overall survival, non-relapse mortality and patient-reported outcomes in chronic GVHD

W. Wood, B. Kurland, J. Pidala, 2014 .

Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease.

W. Wood, B. Kurland, J. Pidala, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Child and parent perspectives of the chronic graft-versus-host disease (cGVHD) symptom experience: a concept elicitation study

J. Lai, M. MacMillan, K. Baird, 2014, Supportive Care in Cancer.

Pentostatin in steroid-refractory acute graft-versus-host disease.

M. Grever, J. Byrd, J. Bolaños-Meade, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

E. Neufeld, F. Trachtenberg, A. Thompson, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT

N. Zhang, P. Hanley, C. Bollard, 2022, Blood advances.

Weight loss and reduced body mass index: a critical issue in children with multiorgan chronic graft-versus-host disease

R. Seshadri, D. Jacobsohn, K. Thormann, 2006, Bone Marrow Transplantation.

Fluticasone, Azithromycin, And Montelukast (FAM) Therapy In Reducing Corticosteroid Exposure In Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplant – A Case Series Of Eight Patients

Stephanie J. Lee, J. Chien, D. Jacobsohn, 2010, Bone Marrow Transplantation.

Fluticasone , azithromycin and montelukast therapy in reducing corticosteroid exposure in bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT : a case series of eight patients

D. Jacobsohn, M. Au, Sj Lee, 2010 .

T cells and natural killer cells regulate human IgG subclass concentrations in SCID mice.

R. Finberg, D. Jacobsohn, D. Ambrosino, 1994, Cellular immunology.

A biomarker panel for risk of early respiratory failure following hematopoietic cell transplantation

Philip R. Gafken, C. Bollard, S. Farag, 2022, Blood advances.

Allogeneic hematopoetic stem cell transplantation in pediatric myelodysplastic syndromes: Improved outcomes for de novo disease

A. Rademaker, W. Tse, I. Helenowski, 2011, Pediatric transplantation.

Hepatitic pattern of graft versus host disease in children

H. Melín‐Aldana, D. Jacobsohn, K. Thormann, 2007, Pediatric blood & cancer.

Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion.

M. Torbenson, J. Boitnott, Linda A. Lee, 2002, Blood.

Clinical importance of confirming or excluding the diagnosis of chronic graft-versus-host disease

D. Jacobsohn, G. Vogelsang, S. Montross, 2001, Bone Marrow Transplantation.

Cellular therapy for sickle cell disease.

C. Bollard, D. Jacobsohn, A. Abraham, 2016, Cytotherapy.

D. Jacobsohn, S. Shenoy, David C. Delgado, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Benefits and challenges with diagnosing chronic and late acute GvHD in children using the NIH consensus criteria.

J. Chewning, G. Cuvelier, D. Coulter, 2019, Blood.

A New Complication of Stem Cell Transplantation: Measles Inclusion Body Encephalitis

W. Bellini, A. Freeman, S. Shulman, 2004, Pediatrics.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report Transplantation and Cellular Therapy

Shannon R. McCurdy, R. Jenq, R. Lafyatis, 2021 .

Transplant Consortium study graft-versus-host disease in children: a Pediatric Blood and Marrow Evaluation of pentostatin in corticosteroid-refractory chronic

A. Rademaker, E. Nemecek, K. Schultz, 2013 .

A phase II prospective study of sequential myeloablative chemotherapy with hematopoietic stem cell rescue for the treatment of selected high risk and recurrent central nervous system tumors

A. Rademaker, S. Goldman, D. Jacobsohn, 2010, Journal of Neuro-Oncology.

Evaluation of pentostatin in corticosteroid-refractory chronic graft-versus-host disease in children: a Pediatric Blood and Marrow Transplant Consortium study.

A. Rademaker, E. Nemecek, L. Lehmann, 2009, Blood.

High WT1 gene expression before haematopoietic stem cell transplant in children with acute myeloid leukaemia predicts poor event‐free survival

A. Rademaker, W. Tse, Wei Huang, 2009, British journal of haematology.

Pentostatin for the treatment of chronic graft-versus-host disease in children.

Allen R. Chen, J. Goldberg, D. Jacobsohn, 2003, Journal of pediatric hematology/oncology.

B ational Institutes of Health Consensus Development roject on Criteria for Clinical Trials in Chronic raft-versus-Host Disease : I . Diagnosis and Staging orking Group Report

M. Turner, J. Wingard, Stephanie J. Lee, 2005 .

Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation.

M. Norkin, M. Aljurf, J. Wingard, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

concentrations (see comments) Recombinant interleukin-2 infusions and decreased IgG2 subclass

J. Ritz, R. Soiffer, D. Ambrosino, 2011 .

Recombinant interleukin-2 infusions and decreased IgG2 subclass concentrations.

J. Ritz, R. Soiffer, D. Ambrosino, 1995, Blood.

Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD

M. Norkin, S. Furlan, M. Pasquini, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease.

D. Jacobsohn, S. Shenoy, M. Hulbert, 2020, Blood advances.

Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression.

Allen R. Chen, S. Meshinchi, M. Loken, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.

P. Hari, J. Varni, W. Tse, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials.

M. Perales, F. Appelbaum, D. Porter, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children

W. Tse, D. Jacobsohn, M. Kletzel, 2004, The Lancet.

Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduce

N. Geller, P. Hari, D. Porter, 2019, The Lancet. Haematology.

Reduced intensity transplants (RIT) in pediatrics: A review

W. Tse, D. Jacobsohn, M. Kletzel, 2005, Pediatric transplantation.

Phase II study of pentostatin in patients with corticosteroid-refractory chronic graft-versus-host disease.

Allen R. Chen, S. Piantadosi, M. Zahurak, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pediatric vulvovaginal graft-versus-host disease: A retrospective cohort study and literature review.

T. Dowlut-McElroy, V. Gomez-Lobo, D. Jacobsohn, 2022, Journal of pediatric and adolescent gynecology.

Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.

M. Sorror, M. Horowitz, J. Wingard, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

PHYSICIAN PERCEPTIONS AND PRACTICE PATTERNS REGARDING FERTILITY PRESERVATION IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS

M. Sorror, J. Wingard, J. Pidala, 2013, Bone Marrow Transplantation.

Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium.

B. Kurland, J. Pidala, Stephanie J. Lee, 2011, Blood.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

Daniel Wolff, Yoshihiro Inamoto, Sandra A Mitchell, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Efficacy of Reduced Intensity Conditioning (RIC) with FLU-BU-ATG and Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Pediatric ALL.

W. Tse, D. Jacobsohn, M. Kletzel, 2004 .

Rapid-onset leucodrema associated with graft-versus-host disease

D. Jacobsohn, K. Ruble, G. Vogelsang, 2002, Bone Marrow Transplantation.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report.

Shannon R. McCurdy, R. Jenq, G. Cuvelier, 2021, Transplantation and cellular therapy.

Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy.

M. Bar, J. Wagner, J. Sierra, 2021, Transplantation and cellular therapy.

Mycoplasma pneumoniae and atypical Stevens–Johnson syndrome in a hematopoietic stem cell transplant recipient

S. Chamlin, D. Jacobsohn, R. Duerst, 2008, Pediatric blood & cancer.

Immune Profile Differences between Chronic GvHD and Late Acute GvHD: Results of the ABLE/PBMTC 1202 Studies.

S. Mostafavi, J. Chewning, G. Cuvelier, 2020, Blood.

Administration of BPX-501 Cells Following Αβ T and B-Cell-Depleted HLA Haploidentical HSCT (haplo-HSCT) in Children with Acute Leukemias (AL)

F. Locatelli, L. Krishnamurti, E. Nemecek, 2019, Biology of Blood and Marrow Transplantation.

Allogeneic hematopoietic SCT for alpha-mannosidosis: an analysis of 17 patients

C. Klein, J. Tolar, J. Kurtzberg, 2012, Bone Marrow Transplantation.

Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning.

M. Sorror, J. Wingard, U. Popat, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia

J. Klein, M. Horowitz, J. Wingard, 2014, Clinical Cancer Research.

Measuring Therapeutic Response in Chronic Graft-versus-host-disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus- Host Disease: Iv. Response Criteria Working Group Report

Daniel Wolff, Anita Lawitschka, Sandra A. Mitchell, 2022 .

Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015

M. Norkin, W. Wood, J. Wingard, 2015, Bone Marrow Transplantation.

Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report

Steven Hirschfeld, Lynn H. Gerber, Sandra A. Mitchell, 2006 .

Age-dependent pharmacokinetic profile of single daily dose i.v. busulfan in children undergoing reduced-intensity conditioning stem cell transplant

W. Tse, J. Schneiderman, D. Jacobsohn, 2009, Bone Marrow Transplantation.

Outcomes of unrelated cord blood transplants and allogeneic-related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia

R. Seshadri, D. Jacobsohn, M. Kletzel, 2004, Bone Marrow Transplantation.

Impact of Hospital Acquired Infections on Post-Transplant One Year Mortality in Pediatric Bone Marrow Transplant Patients.

B. Hanisch, D. Jacobsohn, W. Cohen, 2020, American journal of infection control.

Allogeneic Human Mesenchymal Stem Cell Therapy (Prochymal®) As A Rescue Agent For Severe Treatment Resistant GVHD In Pediatric Patients

J. Kurtzberg, V. Prasad, S. Prockop, 2010 .

Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.

Tao Wang, Thomas Spitzer, Daniel J Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Assessment of Joint and Fascia Manifestations in Chronic Graft‐Versus‐Host Disease

J. Goldberg, B. Kurland, J. Pidala, 2014, Arthritis & rheumatology.

Randomized trial of hydroxychloroquine for newly diagnosed chronic graft-versus-host disease in children: a Children's Oncology Group study.

S. Grupp, B. Langholz, Zhengjia Chen, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Anti-cytokine therapy for the treatment of graft-versus-host disease.

D. Jacobsohn, G. Vogelsang, 2004, Current pharmaceutical design.

Favorable Outcome for Infant ALL Following Hematopoietic Stem Cell Transplantation (HSCT).

D. Jacobsohn, M. Kletzel, E. Morgan, 2004 .

Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.

P. Lachenbruch, B. Reeve, S. Hirschfeld, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced Intensity Unrelated Umbilical Cord Blood Transplantation for Sickle Cell Disease: Results of a Phase I Trial

D. Jacobsohn, S. Shenoy, David C. Delgado, 2017 .

Allogeneic donor availability for hematopoietic stem cell transplantation in children with sickle cell disease

D. Jacobsohn, E. Perez-Albuerne, A. Abraham, 2015, Pediatric blood & cancer.

Immune Reconstitution and Infection Patterns after Early Alemtuzumab and Reduced Intensity Transplantation for Nonmalignant Disorders in Pediatric Patients.

K. Trinkaus, M. Pulsipher, J. Bednarski, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Acute graft-versus-host disease.

D. Jacobsohn, G. Vogelsang, 1990, Cancer treatment and research.

Gastrointestinal toxicity from the preparative regimen is associated with an increased risk of graft-versus-host disease.

J. Goldberg, M. Zahurak, D. Jacobsohn, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Opportunities and challenges of proteomics in pediatric patients: Circulating biomarkers after hematopoietic stem cell transplantation as a successful example

R. Krance, K. Leung, C. Bollard, 2014, Proteomics. Clinical applications.

Granulocyte Colony-Stimulating Factor is Safe and Well Tolerated following Allogeneic Transplantation in Patients with Sickle Cell Disease.

G. Cuvelier, M. Andreánsky, M. Bhatia, 2021, Transplantation and cellular therapy.

High incidence of graft failure in children receiving CD34+ augmented elutriated allografts for nonmalignant diseases

D. Jacobsohn, S. Noga, G. Vogelsang, 2003, Bone Marrow Transplantation.

Pharmacokinetics of a test dose of intravenous busulfan guide dose modifications to achieve an optimal area under the curve of a single daily dose of intravenous busulfan in children undergoing a reduced-intensity conditioning regimen with hematopoietic stem cell transplantation.

D. Jacobsohn, M. Kletzel, R. Duerst, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Nonmyeloablative hematopoietic stem cell transplant for X-linked hyper-immunoglobulin m syndrome with cholangiopathy.

M. O'gorman, H. Melín‐Aldana, D. Jacobsohn, 2004, Pediatrics.

A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality.

M. Robin, M. Pasquini, Richard J. Jones, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Procalcitonin and cytokine profiles in engraftment syndrome in pediatric stem cell transplantation

S. Steinberg, T. Fry, D. Liewehr, 2017, Pediatric blood & cancer.

Measurement of oral chronic GVHD: results from the Chronic GVHD Consortium

B. Kurland, J. Pidala, M. Flowers, 2013, Bone Marrow Transplantation.

Extracorporeal photopheresis performed on the CELLEX® compared with the UVAR‐XTS® instrument is more efficient and better tolerated in children with steroid‐refractory graft‐versus‐host disease

E. Wong, D. Jacobsohn, E. Perez-Albuerne, 2015, Pediatric blood & cancer.

Long-term Survival and Late Effects among 1-year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Syndromes

Zhiwei, Saber, M. Norkin, 2014 .

P. Hari, W. Tse, M. Horowitz, 2018, Haematologica.

The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases.

M. Sorror, J. Kurtzberg, S. Mineishi, 2019, Blood.

Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study

D. Miklos, I. Yakoub-Agha, B. Ko, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Investigator feedback about the 2005 NIH diagnostic and scoring criteria for chronic GVHD

W. Wood, J. Pidala, Stephanie J. Lee, 2014, Bone Marrow Transplantation.

Impact of prior acute GVHD on chronic GVHD outcomes: a chronic graft versus host disease consortium study

B. Kurland, J. Pidala, M. Arora, 2013, Leukemia.

Poor agreement between clinician response ratings and calculated response measures in patients with chronic graft-versus-host disease.

B. Storer, J. Pidala, Stephanie J. Lee, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study

B. Storer, J. Pidala, Stephanie J. Lee, 2012, Haematologica.

Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.

J. Klein, M. Horowitz, J. Wingard, 2011, Blood.

A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 study

J. Chewning, G. Cuvelier, B. Ng, 2022, Blood advances.

Metabolomic Identification of Alpha-Ketoglutaric Acid Elevation in Pediatric Chronic Graft-versus-Host Disease.

J. Chewning, G. Cuvelier, A. Kariminia, 2021, Blood.

A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change.

Li Li, Sandra A Mitchell, Kristin Baird, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Skin response using NIH consensus criteria vs Hopkins scale in a phase II study for steroid-refractory chronic GVHD

A. Rademaker, D. Jacobsohn, G. Vogelsang, 2009, Bone Marrow Transplantation.

Feasibility and Reproducibility of the NIH Consensus Criteria To Evaluate Response in Chronic Graft Versus Host Disease (cGvHD).

B. Reeve, M. Turner, K. Baird, 2006 .

Clinical benefit of response in chronic graft-versus-host disease.

B. Storer, J. Pidala, Stephanie J. Lee, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hand grip strength and 2-minute walk test in chronic graft-versus-host disease assessment: analysis from the Chronic GVHD Consortium.

J. Pidala, Stephanie J. Lee, D. Weisdorf, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Serious Adverse Events in Related Donors: A Report from the Related Donor Safe Study.

M. Horowitz, B. Shaw, G. Switzer, 2021, Transplantation and Cellular Therapy.

Tandem high‐dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high‐risk Ewing family tumors

M. Burke, D. Jacobsohn, M. Kletzel, 2007, Pediatric blood & cancer.

Antigen-specific T cell responses correlate with decreased occurrence of acute GVHD in a multicenter contemporary cohort

C. Bollard, S. Paczesny, E. Chorvinsky, 2021, Bone Marrow Transplantation.

Validation of measurement scales in ocular graft-versus-host disease.

B. Kurland, J. Pidala, Stephanie J. Lee, 2012, Ophthalmology.

Driving the CAR to the Bone Marrow Transplant Program

P. Hanley, C. Bollard, David Jacobsohn, 2019, Current Hematologic Malignancy Reports.

Long‐term survival in a pediatric patient with supratentorial primitive neuro‐ectodermal tumor and extraneural metastasis at diagnosis

J. Fangusaro, T. Tomita, Y. Gosiengfiao, 2011, Pediatric blood & cancer.

Initial therapy for chronic graft-versus-host disease: analysis of practice variation and failure-free survival

J. Pidala, Stephanie J. Lee, M. Arora, 2021, Blood advances.

Assessment of ST2 for risk of death following graft-versus-host disease in the pediatric and adult age groups.

S. Hanash, R. Krance, Hao Liu, 2020, Blood.

The importance of long-term follow-up in pediatric hematopoietic stem cell transplantation

D. Jacobsohn, 2015, Bone Marrow Transplantation.

Use of Mesenchymal Stem Cells To Treat Pediatric Patients with Severe (Grade III–IV) Acute Graft Versus Host Disease Refractory to Steroid and Other Agents on a Compassionate Use Basis.

J. Kurtzberg, V. Prasad, P. Szabolcs, 2007 .

Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort.

J. Klein, M. Horowitz, J. Wingard, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes of pediatric patients with therapy-related myeloid neoplasms

Cheng Cheng, K. Somers, P. Amrolia, 2021, Bone Marrow Transplantation.

FFS: an end(point) to our problems in chronic GVHD trials?

D. Jacobsohn, 2014, Blood.

Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients.

P. Hanley, R. Krance, C. Martinez, 2019, Blood advances.

T Cell Costimulation Blockade with Abatacept Nearly Eliminates Early Severe Acute Graft Versus Host Disease after HLA-Mismatched (7/8 HLA Matched) Unrelated Donor Transplant, with a Favorable Impact on Disease-Free and Overall Survival

M. Norkin, M. Pasquini, S. Choi, 2017 .

Pentostatin in Steroid-Refractory Chronic Graft-Versus-Host Disease.

Allen R. Chen, D. Jacobsohn, G. Vogelsang, 2005 .

Reduced‐toxicity conditioning regimen with busulfan, fludarabine, rATG, and 400 cGy TBI in pediatric patients undergoing hematopoietic stem cell transplant for high‐risk hematologic malignancies

W. Tse, Soyang Kwon, J. Schneiderman, 2021, Pediatric blood & cancer.

Outcomes after Second Hematopoietic Cell Transplantation in Children and Young Adults with Relapsed Acute Leukemia.

V. Brown, Chi-kong Li, K. Myers, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predicting chronic GVHD outcomes: are we there yet?

D. Jacobsohn, 2016, Blood.

B. Kurland, M. Flowers, M. Arora, 2012 .

Case report: Tisagenlecleucel for treatment of relapsed B- acute lymphoblastic leukemia in a patient with CHEK2 mutation

A. Angiolillo, Jinjun Cheng, D. Jacobsohn, 2023, Frontiers in Pediatrics.

Shedding some LIGHT on chronic GVHD.

D. Jacobsohn, 2008, Blood.

Feasibility and Reproducibility of the New NIH Consensus Criteria To Evaluate Response in Chronic GvHD - A Pilot Study.

B. Reeve, M. Turner, S. Mitchell, 2005 .

Preliminary Results from the AdVise Study Evaluating Brincidofovir (CMX001, BCV) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection

T. Brundage, V. Prasad, H. Momméja-Marin, 2015 .

Late effects of stem cell transplantation in brain tumor survivors.

D. Jacobsohn, K. Danner-Koptik, Kimberley J. Dilley, 2009, Cancer treatment and research.

Pentostatin: Efficacy in Refractory Chronic GVHD in Children.

Allen R. Chen, D. Jacobsohn, K. Thormann, 2004 .

Diagnosis and Management of Pediatric Transplant-associated Viral Infections

R. DeBiasi, B. Hanisch, D. Jacobsohn, 2016, The Pediatric infectious disease journal.

T Cell Costimulation Blockade with CTLA4-Ig (Abatacept) for Acute Gvhd Prevention in HLA Matched and Mismatched Unrelated Donor Transplantation: Results of the First Phase 2 Trial

M. Norkin, M. Pasquini, M. Tighiouart, 2019, Biology of Blood and Marrow Transplantation.

Acute graft versus host disease.

D. Jacobsohn, G. Vogelsang, 2007 .

Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis Obliterans Syndrome (BOS) after Hematopoietic Cell Transplantation

B. Storer, J. Pidala, Stephanie J. Lee, 2015 .

Acute graft versus host disease.

D. Jacobsohn, G. Vogelsang, 2007 .

SECOND MALIGNANCIES AFTER AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION IN CHILDREN

W. Wood, M. Sorror, J. Wingard, 2012, Bone Marrow Transplantation.

Higher Abatacept Exposure Decreases Acute GVHD Risk Without Increasing Adverse Events.

D. Neuberg, S. Choi, B. Blazar, 2023, Blood.

Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.

B. Storer, J. Pidala, Stephanie J. Lee, 2011, Blood.

Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report.

J. Pidala, M. Flowers, S. Pavletic, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort.

M. Horowitz, J. Wingard, R. Gale, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

P. Lachenbruch, B. Reeve, S. Hirschfeld, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Randomized trial of hydroxychloroquine for newly diagnosed chronic graft-versus-host disease in children: a Children's Oncology Group study.

S. Grupp, B. Langholz, Zhengjia Chen, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study.

J. Kurtzberg, G. Broadwater, V. Prasad, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Measuring Therapeutic Response In Chronic Graft-Versus-Host Disease.

D. Jacobsohn, Y. Inamoto, J. Koreth, 2009 .

Shedding some LIGHT on chronic GVHD.

D. Jacobsohn, 2008, Blood.

Mycoplasma pneumoniae and atypical Stevens–Johnson syndrome in a hematopoietic stem cell transplant recipient

S. Chamlin, D. Jacobsohn, R. Duerst, 2008, Pediatric blood & cancer.

Chronic Graft-Versus-Host Disease Risk Score: A CIBMTR Analysis

M. Horowitz, J. Wingard, R. Gale, 2010 .

Pediatric vulvovaginal graft-versus-host disease: A retrospective cohort study and literature review.

V. Gomez-Lobo, D. Jacobsohn, Elizabeth Stepanek, 2022, Journal of pediatric and adolescent gynecology.

Clinical Research: Supportive CareFluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation

B. Storer, J. Pidala, Stephanie J. Lee, 2016 .

Evaluation of pentostatin in corticosteroid-refractory chronic graft-versus-host disease in children: a Pediatric Blood and Marrow Transplant Consortium study.

A. Rademaker, L. Lehmann, K. Schultz, 2009, Blood.